Senestech, Inc. (NASDAQ:SNES – Get Free Report) major shareholder Glenbrook Capital Management purchased 7,956 shares of the stock in a transaction that occurred on Thursday, February 12th. The stock was bought at an average price of $1.72 per share, with a total value of $13,684.32. Following the completion of the acquisition, the insider owned 618,310 shares in the company, valued at $1,063,493.20. This represents a 1.30% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
Glenbrook Capital Management also recently made the following trade(s):
- On Friday, February 13th, Glenbrook Capital Management acquired 15,390 shares of Senestech stock. The shares were bought at an average price of $1.89 per share, for a total transaction of $29,087.10.
- On Wednesday, February 11th, Glenbrook Capital Management purchased 8,000 shares of Senestech stock. The shares were bought at an average cost of $1.73 per share, for a total transaction of $13,840.00.
- On Thursday, February 5th, Glenbrook Capital Management bought 2,884 shares of Senestech stock. The shares were purchased at an average cost of $1.77 per share, for a total transaction of $5,104.68.
- On Wednesday, February 4th, Glenbrook Capital Management acquired 5,685 shares of Senestech stock. The stock was purchased at an average cost of $1.82 per share, with a total value of $10,346.70.
- On Monday, February 2nd, Glenbrook Capital Management purchased 42,739 shares of Senestech stock. The stock was acquired at an average cost of $1.98 per share, with a total value of $84,623.22.
- On Friday, January 30th, Glenbrook Capital Management acquired 5,399 shares of Senestech stock. The shares were acquired at an average price of $1.87 per share, for a total transaction of $10,096.13.
Senestech Stock Up 12.4%
Shares of SNES traded up $0.22 during trading on Friday, reaching $2.00. The company’s stock had a trading volume of 44,882 shares, compared to its average volume of 45,234. The company has a market cap of $10.44 million, a price-to-earnings ratio of -0.55 and a beta of 0.21. The company has a quick ratio of 14.73, a current ratio of 15.75 and a debt-to-equity ratio of 0.01. The company has a fifty day moving average of $2.19 and a two-hundred day moving average of $3.44. Senestech, Inc. has a twelve month low of $1.30 and a twelve month high of $6.24.
Analyst Ratings Changes
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Senestech in a report on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Senestech presently has a consensus rating of “Hold”.
View Our Latest Report on SNES
Institutional Investors Weigh In On Senestech
Institutional investors and hedge funds have recently modified their holdings of the stock. Geode Capital Management LLC acquired a new position in shares of Senestech in the 2nd quarter worth $59,000. Jane Street Group LLC purchased a new stake in shares of Senestech during the fourth quarter valued at $32,000. Diversify Advisory Services LLC acquired a new position in shares of Senestech in the 4th quarter valued at $34,000. Essex Investment Management Co. LLC acquired a new position in shares of Senestech in the 3rd quarter valued at $115,000. Finally, Millennium Management LLC purchased a new position in Senestech in the 3rd quarter worth about $126,000. Institutional investors and hedge funds own 5.19% of the company’s stock.
Senestech Company Profile
SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.
The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.
Read More
- Five stocks we like better than Senestech
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- New gold price target
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
